Fortrea
Ranga Narasimhan is a seasoned financial professional with extensive experience in various leadership roles across multiple industries. Currently serving as Head of Finance for Fortrea India since July 2023, Ranga is leading efforts during the stabilization phase post-spin-off from Labcorp. Prior to this role, Ranga held the position of Senior Director of Finance at Labcorp Drug Development, where responsibilities included post-acquisition integration and team development. Experience at HP involved overseeing global controllership initiatives and tax compliance programs, while previous roles at Cisco and Motorola focused on financial controllership and strategic decision support. Ranga holds several academic qualifications, including a CPA from Australia and various management and financial certifications from recognized institutions.
This person is not in any teams
This person is not in any offices
Fortrea
11 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.